A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Clinical trial NCT07071623 · RECRUITING

Trial details

NCT number: NCT07071623
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis

Start date: 2025-11-10
Primary completion: 2027-10-18
Enrollment: 4580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.